Therapeutic Asset Ratings
9,928 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Ceralasertib
Gastric Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Ceralasertib
Gastroesophageal Junction Adenocarcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Ceralasertib
Salivary Gland Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Ceralasertib
High Grade Malignant Neoplasm
AstraZeneca
P1
CC
(43)
Ceralasertib
Gastric Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Ceralasertib
HER2 Positive Breast Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Ceralasertib
Hepatobiliary Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
Ceralasertib
Colon Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Ceralasertib
Neoplasm
AstraZeneca
P1
CC
(43)
Ceralasertib
Colorectal Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Ceralasertib
Major Salivary Gland Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Ceralasertib
Uterine Corpus Endometrial Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Ceralasertib
Uterine Corpus Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Ceramide Nanoliposome
Acute Myeloid Leukemia
Keystone Nano, Inc
P1
CC
(43)
Certepetide
Peritoneal Carcinomatosis
University of California, San Diego
P1
CC
(43)
Cetuximab
Gastroesophageal Junction Adenocarcinoma
BeOne Medicines
P1
CC
(43)
Cetuximab
Endometrial Carcinoma
Fate Therapeutics
P1
CC
(43)
Cetuximab
Acute Lymphoblastic Leukemia
City of Hope Medical Center
P1
CC
(43)
Cetuximab-Irdye800
Malignant Glioma
University Medical Center Groningen
P1
CC
(43)
cf33-hnis
Bile Duct Cancer
Imugene Limited
P1
CC
(43)
cg-0255 besylate
Acute Coronary Syndrome
Shanghai CureGene Pharmaceutical Co., Ltd.
P1
CC
(43)
cg-0255 besylate
Peripheral Arterial Disease
Shanghai CureGene Pharmaceutical Co., Ltd.
P1
CC
(43)
cg-0255 besylate
Myocardial Infarction
Shanghai CureGene Pharmaceutical Co., Ltd.
P1
CC
(43)
cg-0255 besylate
Stroke Disorder
Shanghai CureGene Pharmaceutical Co., Ltd.
P1
CC
(43)
cg-0255 besylate for
Acute Coronary Syndrome
Shanghai CureGene Pharmaceutical Co., Ltd.
P1
CC
(43)
Showing 1601 to 1625 of 9,928 assets
Previous
Page 65 of 398
Next